WuXi Biologics to invest $1.4bn to expand CRDMO facility in Singapore
The investment will strengthen WuXi Biologics’ global research, development and manufacturing network to meet the growing demand from…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
20 Jul 22
The investment will strengthen WuXi Biologics’ global research, development and manufacturing network to meet the growing demand from…
19 Jul 22
Enterome will receive a €40m upfront payment in cash and equity and is eligible to receive additional payments,…
19 Jul 22
Haleon includes a portfolio of global brands including Advil, Centrum, Sensodyne, Robitussin, and TUMS and is expected to…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
18 Jul 22
The EC granted conditional marketing authorisation for Kinpeygo based on the efficacy and safety data from Part A…
15 Jul 22
Theravance will receive total consideration of more than $1.5bn, including around $1.1bn in an upfront payment, and up…
14 Jul 22
The US FDA granted the EUA based on data from the Phase 3 PREVENT-19 clinical trial, in which…
13 Jul 22
GenScript ProBio will support ACT therapeutics’ CAR-T Platform (ACT platform), an immune cell-based cell and gene therapy technology…
12 Jul 22
Ionis will receive $55m from Roche, in exchange for licensing IONIS-FB-LRx and achieving a development milestone in the…
11 Jul 22
The UK health regulator indicated Tecovirimat for the treatment of smallpox, monkeypox, cowpox, and vaccinia complications, after vaccination…
11 Jul 22
As per the agreement, the companies will develop and market Zynlonta for all hematologic and solid tumour indications,…